RAPT Therapeutics, Inc. (RAPT) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

4,753,182Shares Outstanding

566,815Shares held by institutions

$32,784,601Value of institutional holdings

91.46%Institutional ownership %

2.97%Shares Changed QoQ

97No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

A total of 103 institutions have reported a stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT) as of December 2025, according to recent 13F filings with the SEC.

The percentage of RAPT Therapeutics owned by institutions changed from 61.4% in September 2025 to 109.7% in December 2025, marking a slight up trend.
Institutional share ownership changed by 90.11% QoQ, while the number of institutional owners saw an increase of 10.75% YoY.
The latest 13F cycle for RAPT Therapeutics reveals that of 103 total investors, 83 funds grew their exposure, whereas 9 reduced theirs and 11 made no changes.
Collectively, institutional investors increased their stake in RAPT Therapeutics to 29.66Mn shares as of December 2025, a change that is up by 14.06Mn shares quarter on quarter and up 13.77Mn shares year over year.
Medicxi Ventures Management (Jersey) Ltd continues to be the largest institutional holder of RAPT Therapeutics as of December 31, 2025, with a position of 2.79Mn shares, representing 10.33% of the company's outstanding stock.
Among the most significant buyers of RAPT Therapeutics during December 2025 were FCPM III SERVICES B.V. (1.49Mn), Frazier Life Sciences Management, L.P. (983.33K), TCG Crossover Management, LLC (946.13K), BRAIDWELL LP (929.69K), Siren, L.L.C. (794.53K).
Leading sellers of RAPT Therapeutics stock in December 2025 included Deep Track Capital, LP (640.97K), BOONE CAPITAL MANAGEMENT LLC (312.00K), ROYAL BANK OF CANADA (14.42K), Column Group LLC (9.80K), BRIDGEWAY CAPITAL MANAGEMENT, LLC (6.25K).
The top 10 institutional holders of RAPT Therapeutics for the quarter ending December 2025 included Medicxi Ventures Management (Jersey) Ltd (2.79Mn), TCG Crossover Management, LLC (2.58Mn), FCPM III SERVICES B.V. (1.83Mn), ORBIMED ADVISORS LLC (1.64Mn), RTW INVESTMENTS, LP (1.64Mn), Foresite Capital Management VI LLC (1.56Mn), Siren, L.L.C. (1.38Mn), VANGUARD GROUP INC (1.19Mn), Frazier Life Sciences Management, L.P. (983.33K), BRAIDWELL LP (929.69K).

103 Institutional Holders

566,815 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
Medicxi Ventures Management (Jersey) Ltd	31 Dec, 2025	2,794,000	0	0.00%	$94,632,780.00
TCG Crossover Management, LLC	31 Dec, 2025	2,582,408	946,133	57.82%	$87,466,159.00
FCPM III SERVICES B.V.	31 Dec, 2025	1,833,333	1,489,096	432.58%	$62,094,989.00
ORBIMED ADVISORS LLC	31 Dec, 2025	1,642,891	556,273	51.19%	$55,644,718.00
RTW INVESTMENTS, LP	31 Dec, 2025	1,637,165	166,666	11.33%	$55,450,779.00
Foresite Capital Management VI LLC	31 Dec, 2025	1,562,500	0	0.00%	$52,921,875.00
Siren, L.L.C.	31 Dec, 2025	1,375,000	794,534	136.88%	$46,571,250.00
VANGUARD GROUP INC	31 Dec, 2025	1,186,791	490,603	70.47%	$40,196,611.00
Frazier Life Sciences Management, L.P.	31 Dec, 2025	983,333	983,333	0.00%	$33,305,489.00
BRAIDWELL LP	31 Dec, 2025	929,694	929,694	0.00%	$31,488,736.00
Redmile Group, LLC	31 Dec, 2025	885,927	333,333	60.32%	$30,006,347.00
PERCEPTIVE ADVISORS LLC	31 Dec, 2025	825,890	642,000	349.12%	$27,972,894.00
Soleus Capital Management, L.P.	31 Dec, 2025	764,000	226,097	42.03%	$25,876,680.00
Nantahala Capital Management, LLC	31 Dec, 2025	754,153	130,871	21.00%	$25,543,162.00
Caligan Partners LP	31 Dec, 2025	644,400	644,400	0.00%	$21,825,828.00
STATE STREET CORP	31 Dec, 2025	639,804	602,421	1,611.48%	$21,670,161.00
CITADEL ADVISORS LLC	31 Dec, 2025	591,802	576,272	3,710.70%	$20,044,334.00
GREAT POINT PARTNERS LLC	31 Dec, 2025	581,187	581,187	0.00%	$19,684,804.00
Octagon Capital Advisors LP	31 Dec, 2025	574,000	574,000	0.00%	$19,441,380.00
ADAR1 Capital Management, LLC	31 Dec, 2025	509,679	1,908	0.38%	$17,262,828.00

1 - 20 of 103

Research Tools